ALB 📈 Albemarle - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0126531013
ALB: Lithium, Bromine, Catalysts, Chemicals, Zirconium, Barium, Titanium
Albemarle Corporation is a global developer, manufacturer, and marketer of engineered specialty chemicals, with a diverse portfolio of products that cater to various industries. The company's operations are segmented into three main categories: Energy Storage, Specialties, and Ketjen. The Energy Storage segment is a key player in the lithium market, offering a range of lithium compounds such as lithium carbonate, lithium hydroxide, and lithium chloride, which are essential for the production of lithium-ion batteries used in electric vehicles, consumer electronics, and renewable energy systems. Additionally, this segment provides technical services for handling and using reactive lithium products, as well as lithium-containing by-products recycling services, which helps to minimize waste and reduce the environmental impact of lithium production.
The Specialties segment is another significant contributor to Albemarle's business, providing a broad range of bromine-based specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals. These products have various applications, including the manufacture of pharmaceuticals, agrochemicals, and water treatment chemicals. This segment also develops and manufactures cesium products for the chemical and pharmaceutical industries, as well as zirconium, barium, and titanium products for pyrotechnical applications, such as airbag initiators. Furthermore, the company offers lithium specialties like butyllithium and lithium aluminum hydride, which are used as catalysts and reagents in various chemical reactions.
The Ketjen segment focuses on the development and manufacture of catalysts and additives for the petroleum refining, petrochemical, and automotive industries. The company's clean fuels technologies (CFT) portfolio includes hydroprocessing catalysts (HPC), isomerization and akylation catalysts, fluidized catalytic cracking (FCC) catalysts and additives, and performance catalyst solutions (PCS), which comprise organometallics and curatives. These products help to improve the efficiency and yield of refining processes, reduce emissions, and produce higher-quality fuels and petrochemicals. With a rich history dating back to 1887, Albemarle Corporation has established itself as a leading player in the specialty chemicals industry, serving a wide range of markets, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection.
As a global company with a strong online presence, Albemarle Corporation can be found at https://www.albemarle.com, providing easy access to information about its products, services, and investor relations. With its common stock listed under the ISIN US0126531013 and classified under the GICS Sub Industry: Specialty Chemicals, Albemarle Corporation is a notable entity in the chemical industry, with its headquarters located in Charlotte, North Carolina. The company's commitment to innovation, quality, and customer satisfaction has enabled it to maintain a strong position in the market, with a diverse customer base and a wide range of applications for its products.
Additional Sources for ALB Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ALB Stock Overview
Market Cap in USD | 12,659m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception | 1994-02-17 |
ALB Stock Ratings
Growth 5y | 4.37% |
Fundamental | -46.9% |
Dividend | 55.0% |
Rel. Strength Industry | -1339 |
Analysts | 3.57/5 |
Fair Price Momentum | 78.16 USD |
Fair Price DCF | - |
ALB Dividends
Dividend Yield 12m | 1.82% |
Yield on Cost 5y | 2.35% |
Annual Growth 5y | 1.68% |
Payout Consistency | 97.1% |
ALB Growth Ratios
Growth Correlation 3m | 43.5% |
Growth Correlation 12m | -69% |
Growth Correlation 5y | 16.6% |
CAGR 5y | 5.27% |
CAGR/Mean DD 5y | 0.18 |
Sharpe Ratio 12m | -0.68 |
Alpha | -76.50 |
Beta | 1.49 |
Volatility | 55.15% |
Current Volume | 3685.7k |
Average Volume 20d | 1901.6k |
As of December 21, 2024, the stock is trading at USD 88.65 with a total of 3,685,669 shares traded.
Over the past week, the price has changed by -10.80%, over one month by -18.76%, over three months by +3.45% and over the past year by -36.84%.
Probably not. Based on ValueRay Fundamental Analyses, Albemarle (NYSE:ALB) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -46.90 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALB as of December 2024 is 78.16. This means that ALB is currently overvalued and has a potential downside of -11.83%.
Albemarle has received a consensus analysts rating of 3.57. Therefor, it is recommend to hold ALB.
- Strong Buy: 8
- Buy: 3
- Hold: 15
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, ALB Albemarle will be worth about 86.4 in December 2025. The stock is currently trading at 88.65. This means that the stock has a potential downside of -2.57%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 116.4 | 31.3% |
Analysts Target Price | 251.2 | 183.4% |
ValueRay Target Price | 86.4 | -2.6% |